Biomarkers are measurable indicators of biological processes, providing crucial insights into Alzheimer’s disease (AD) for early detection, tracking progression, and evaluating therapeutic efficacy. The search for reliable biomarkers focuses on detecting Alzheimer’s before significant cognitive decline occurs, enabling earlier interventions and improved outcomes. Current advancements include imaging techniques, bio fluid assays, and genetic markers. These tools are revolutionizing clinical practices, offering non-invasive, accurate methods to diagnose Alzheimer’s and predict its progression.
Track 2:1 Neuroimaging Biomarkers
Track 2:2 Fluid Biomarkers
Track 2:3 Genetic and Epigenetic Biomarkers
Track 2:4 Metabolic and Proteomic Biomarkers
Track 2:5 Multimodal Biomarker Approaches
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
